Axis Capital Limited, Credit Suisse Securities (India) Private Limited, IIFL Holdings Limited, Kotak Mahindra Capital Company Limited
Krishna Institute of Medical Sciences Limited (“KIMS”) was incorporated as Jagjit Singh and Sons Private Limited on July 26, 1973. KIMS is one of the largest corporate healthcare groups in AP and Telangana in terms of number of patients treated and treatments offered. They operate 9 multispecialty hospitals under the “KIMS Hospitals” brand, with an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021, which are 2.2 times more beds than the 2nd largest provider in AP and Telangana. KIMS offers a comprehensive range of healthcare services across over 25 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopedics, organ transplantation, renal sciences and mother & child care. Dr. Bhaskara Rao Bollineni, Rajyasri Bollineni, Dr. Abhinay Bollineni, Adwik Bollineni, and Bollineni Ramanaiah Memorial Hospitals Private Limited are the company promoters.
For year/ period ended ( in Cr.)
31 Mar 2021 | 31 Mar 2020 | 31 Mar 2019 | |
---|---|---|---|
Total Revenue | 1329.94 | 1122.65 | 918.01 |
Profit After Tax | 205.48 | 115.07 | -48.81 |
EPS | 26.87 | 15.87 | -5.32 |
OPM(%) | 28.43% | 22.24% | 18.83% |
PATM(%) | 15.45% | 10.25% | -5.32% |
The Company is growing at ~26% CAGR basis in last 3 years which is highest in among peers. Considering the growth prospects of healthcare sector & company’s expansion plan will beneficial for its near future. Hence, investor can subscribe to the issue for the medium to long-term.
Never Miss IPO Investment